Carregant...
MET in human cancer: germline and somatic mutations
Since the initial discovery of missense MET mutations in hereditary papillary renal carcinoma (HPRC), activating MET mutations have been identified in a diverse range of human cancers. MET mutations have been identified in several functional domains including the kinase, juxtamembrane, and Sema doma...
Guardat en:
| Publicat a: | Ann Transl Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451609/ https://ncbi.nlm.nih.gov/pubmed/28603720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.03.64 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|